StockWatch
·
Trading - Chemicals
Quarterly Result26 Oct 2026, 01:20 pm

Vinyl Chemicals Q2 FY27: standalone PAT up 4x YoY to ₹11.4 Cr, revenue +44%

AI Summary

Vinyl Chemicals (India) reported standalone revenue from operations of ₹218.57 Cr for Q2 FY27, up 43.9% YoY from ₹151.89 Cr, with PAT of ₹11.41 Cr versus ₹2.88 Cr a year ago (+296%) and NPM expanding to 5.25% from 1.88%. Part of the YoY jump is a low-base effect — Q2 FY26 PAT had itself fallen sharply from the prior year — so the step-change overstates the underlying run-rate even though both revenue and PAT grew together this quarter, unlike a pure base-effect bounce. Sequentially the picture is more moderate: revenue rose 119.4% QoQ but PAT only 72.4%, so NPM compressed from Q1 FY27's 6.25% to 5.25%. That's mainly a trading-cost-timing effect — Q1's margin was flattered by a large inventory build-up that temporarily held down cost of goods sold in the P&L, while Q2 saw inventories drawn down, pulling the cost line back up. A ₹1.76 Cr forex gain embedded within expenses (versus a ₹1.64 Cr forex expense a year ago) also aided the quarter, while "other income" turned negative at -₹1.24 Cr (versus +₹1.27 Cr YoY), a modest non-operating drag likely tied to investment mark-to-market. There is no prior management guidance or concall commentary on record to grade this print against, and no management press release beyond the routine stock-exchange intimation — both are explicitly absent rather than simply unaddressed. A web check found no analyst or consensus estimates for this micro-cap trading company (Simply Wall St notes no analyst forecasts exist for the stock), so there is no street bar to compare against either. Notably, H1 FY27 PAT of ₹18.03 Cr has already surpassed full-year FY26 PAT of ₹16.50 Cr. The revenue ramp was funded by a sharp build in working capital: inventories rose to ₹91.30 Cr from ₹32.56 Cr at FY26-end, trade receivables to ₹150.39 Cr from ₹123.41 Cr, and trade payables to ₹140.08 Cr from ₹95.82 Cr. With no formal guidance to anchor expectations, the key read-through for next quarter is whether these working-capital levels and the forex/other-income swings normalize.

Key Highlights

  • Standalone PAT ₹11.41 Cr vs ₹2.88 Cr YoY (+296%), vs ₹6.62 Cr QoQ (+72%)
  • Revenue from operations ₹218.57 Cr, +43.9% YoY, +119.4% QoQ — single segment (trading in chemicals)
  • NPM 5.25% this quarter vs 1.88% YoY (expansion) but down from 6.25% in Q1 FY27, due to inventory-cost timing
  • No exceptional items; ₹1.76 Cr forex gain embedded in expenses (vs ₹1.64 Cr forex expense YoY) aided the print
  • Other income turned negative at -₹1.24 Cr vs +₹1.27 Cr YoY — a modest non-operating drag
  • EPS basic ₹6.24 for the quarter (not annualised) vs ₹1.58 YoY and ₹3.61 QoQ
  • H1 FY27 PAT of ₹18.03 Cr already exceeds full FY26 PAT of ₹16.50 Cr
  • Inventories up to ₹91.30 Cr (from ₹32.56 Cr) and trade payables up to ₹140.08 Cr (from ₹95.82 Cr), funding the revenue ramp